Project Grant R01AI191564
- Federal Project Grant Award Summary Rutgers The State University of New Jersey, Robert Wood Johnson School of Health Sciences-School of Nursing received a $235,500 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective July 1, 2025, through June 30, 2027. This award supports investigator-initiated biomedical research focused on understanding host-pathogen interactions between...
- Federal Grant Award Summary Rutgers The State University of New Jersey, School of Nursing, received a $416,121 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 11, 2025, with a completion date of May 31, 2027. This award supports investigator-initiated biomedical research examining the role of TBet+ B cells in viral reinfection and host protection. The research will advance...
- Federal Grant Award Summary Rutgers The State University of New Jersey, School of Nursing, received a $781,369 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded August 13, 2025, with completion scheduled for July 31, 2030. This research initiative investigates the regulatory role of B cells in lung granulomatous inflammation associated with chronic tuberculosis (TB), a condition...
- Federal Grant Award Summary Rutgers, The State University received a $158,000 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) on June 9, 2025, with a completion date of May 31, 2027. The grant supports biomedical research investigating the mechanisms by which Pseudomonas aeruginosa, a major nosocomial pathogen responsible for wound, bloodstream, and lung infections, resists nitric...
- Federal Grant Award Summary Award Details: Rutgers The State University of New Jersey (RBHS-School of Nursing) received a $3.09 million Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award was obligated on September 10, 2025, with a completion date of August 31, 2030. Products and Services: The FEND-TB (Ending TB) initiative delivers a comprehensive pipeline to accelerate...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded Rutgers The State University of New Jersey—Robert Wood Johnson Medical School (RBHS-School of Nursing) a Project Grant of $1,041,944 under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective September 11, 2025, with a completion date of August 31, 2030. This award supports investigator-initiated biomedical research focused on understanding host-bacterial...
- Federal Project Grant Award Summary Rutgers The State University of New Jersey (RBHS-School of Nursing) received a $1,032,233 Project Grant award from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective September 10, 2025, through August 31, 2030. The project, titled "Transmission Links and Clinical Spectrum of Exhaled Mycobacterium Tuberculosis," delivers investigative research services focused...
- Federal Grant Award Summary Rutgers The State University of New Jersey (RBHS-School of Nursing) received a $272,133 Project Grant from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded June 18, 2025, with completion targeted for May 31, 2027. The award supports the development of a low-cost, instrument-free rapid antigen test for diagnosing active Hepatitis C Virus (HCV) infection. The research aims to...
- Federal Grant Award Summary Rutgers The State University of New Jersey received a $160,640 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025 through July 31, 2027. This award supports research investigating the mechanistic role of the mechanistic target of rapamycin (mTOR) signaling pathway in human and murine cryptococcosis susceptibility. The research aims to...
- Federal Grant Award Summary Rutgers The State University of New Jersey (RBHS-School of Nursing) received a $445,250 Project Grant award from the National Institute of Allergy and Infectious Diseases under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 6, 2025, through July 31, 2027. This research project will establish a mouse model of congenital syphilis (CS) caused by Treponema pallidum subspecies pallidum (TP), assess pathogen persistence, and...
Rutgers The State University of New Jersey, School of Nursing received a $764,590 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 1, 2026 through January 31, 2031. The award supports investigative research examining the ontogeny and functions of trained macrophages in type 2 immunity, with particular focus on understanding immune responses to helminth parasitic infections. The research will characterize how lung macrophages maintain protective antimicrobial functions and achieve trained immunity status through interactions with other innate immune cells, including neutrophils and basophils, with the objective of developing therapeutic strategies to improve parasite expulsion while mitigating severe immunopathological complications such as emphysema and pulmonary fibrosis. The research deliverables will contribute to fundamental immunological knowledge regarding the regulation of type 2 inflammatory responses and macrophage activation mechanisms in parasitic infection contexts. Through this five-year project period, the awardee will conduct basic science investigations and generate data that may inform development of novel therapeutics targeting innate immune pathways relevant to helminth infections affecting an estimated 2 billion people globally. The research is performed at the awardee's Newark, New Jersey location.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $764.6k | 2/1/26 |